Must Read Rumors

Prince Harry and Meghan Markle are “total homebodies” at Kensington Palace

Prince Harry is always on the road for his royal engagements. His girlfriend Meghan Markle is also busy as an actress. But in between they manage to make time to see each other.

Kate Middleton and Prince William will take George and Charlotte on royal tour of Poland and Germany

Prince George and Princess Charlotte will accompany the Duke and Duchess of Cambridge on their upcoming European tour.

Duchess Kate debuts new haircut at Wimbledon

Prince William’s wife appeared at Wimbledon with a new elegant and refined haircut that didn’t go unnoticed.

Kate Middleton to attend opening of Wimbledon tennis championships

An avid tennis fan for many years, the Duchess of Cambridge, née Kate Middleton, will be present on the first day of the Wimbledon Championships this year.

Kate Middleton reveals mom Carole Middleton’s crush on Roger Federer

The Duchess of Cambridge, née Kate Middleton, was invited to participate in a documentary about tennis and she made some revelations about her parents during the interview.

Prince Harry and Meghan Markle are “total homebodies” at Kensington Palace
Kate Middleton and Prince William will take George and Charlotte on royal tour of Poland and Germany
Duchess Kate debuts new haircut at Wimbledon
Kate Middleton to attend opening of Wimbledon tennis championships
Kate Middleton reveals mom Carole Middleton’s crush on Roger Federer

The Bluetooth pill to appear in European hospitals soon

by Nicole
November 12, 2010 at 3:22 pm

Miniaturization has always been a safe way to remarkable advances in microprocessor industry, allowing not only the manufacturing of microchips, but also a greater degree of integration for equipment with a high degree of complexity.

One of the areas that most benefit this is medicine, a domain in which miniaturization has enabled the creation of more sophisticated prostheses, and intelligent diagnostic equipment, small enough to fit inside a capsule.

One of the first companies to bring such devices in mass production is Novartis AG Sweden, with its “Ingestible Event Marker.” Small enough to be incorporated into the pill capsules, this microchip, activated after ingestion by contact with the stomach acids, may send biometric information to assess the effectiveness of the administered drug.

Parameters such as body temperature, heart rate and movements of the patient can be monitored, as information is transmitted in real time via Bluetooth.

Initially, this technology will be used only for monitoring high-risk patients such as those undergoing transplant operations, but could be extended to other areas.

If tests show that adding such microchips does not change the curative properties of pills, the product could be approved for general use in European countries over the next 18 months.

What do you think? What is your gossip?

The rules: Keep it clean, stay on the subject and use English only - or we may delete your comment. If you see inappropriate language email us. Read our Terms and Conditions